Tocagen Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 13

  • Investments
  • 1

Tocagen General Information

Description

Tocagen Inc is a clinical-stage, cancer-selective gene therapy company. It is focused on developing product candidates designed to activate a patient's immune system against their own cancer from within. The company's cancer-selective gene therapy platform is built on retroviral replicating vectors, or RRVs, which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. Tocagen is developing product candidate, Toca 511 and Toca FC, for the treatment of recurrent high grade glioma, or HGG, a brain cancer with limited treatment options, low survival rates and, therefore, a significant unmet medical need. Geographically, the activities are carried out through United States.

Contact Information

Website
www.tocagen.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4242 Campus Point Court
  • Suite 600
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 4242 Campus Point Court
  • Suite 600
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tocagen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tocagen‘s full profile, request access.

Request a free trial

Tocagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Tocagen Inc is a clinical-stage, cancer-selective gene therapy company. It is focused on developing product candidates d
Drug Discovery
San Diego, CA
9 As of 2020

Boston, MA
 

Framingham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tocagen Competitors (25)

One of Tocagen’s 25 competitors is Aura Biosciences, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aura Biosciences Formerly VC-backed Boston, MA
Xenetic Biosciences Corporation Framingham, MA
Iovance Biotherapeutics Corporation San Carlos, CA
Mustang Bio Formerly VC-backed Waltham, MA
Kite Pharma Formerly VC-backed Santa Monica, CA
You’re viewing 5 of 25 competitors. Get the full list »

Tocagen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tocagen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tocagen‘s full profile, request access.

Request a free trial

Tocagen Acquisitions (1)

Tocagen’s most recent deal was a Reverse Merger with Forte Biosciences for . The deal was made on 16-Jun-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Forte Biosciences 16-Jun-2020 Reverse Merger Drug Discovery
To view Tocagen’s complete acquisitions history, request access »

Tocagen Exits (1)

Tocagen’s most recent exit was on 16-Jun-2020 from Forte Biosciences. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Forte Biosciences 16-Jun-2020 Completed
To view Tocagen’s complete exits history, request access »

Tocagen FAQs

  • When was Tocagen founded?

    Tocagen was founded in 2007.

  • Where is Tocagen headquartered?

    Tocagen is headquartered in San Diego, CA.

  • What is the size of Tocagen?

    Tocagen has 9 total employees.

  • What industry is Tocagen in?

    Tocagen’s primary industry is Drug Discovery.

  • Is Tocagen a private or public company?

    Tocagen is a Private company.

  • What is the current valuation of Tocagen?

    The current valuation of Tocagen is .

  • What is Tocagen’s current revenue?

    The current revenue for Tocagen is .

  • How much funding has Tocagen raised over time?

    Tocagen has raised $209M.

  • Who are Tocagen’s investors?

    Accelerate Brain Cancer Cure, Biobrit, Foresite Capital, National Brain Tumor Society, and The American Brain Tumor Association are 5 of 6 investors who have invested in Tocagen.

  • Who are Tocagen’s competitors?

    Aura Biosciences, Xenetic Biosciences, Iovance Biotherapeutics, Mustang Bio, and Kite Pharma are some of the 25 competitors of Tocagen.

  • When was Tocagen acquired?

    Tocagen was acquired on 15-Jun-2020.

  • Who acquired Tocagen?

    Tocagen was acquired by Forte Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process